The work of the ITN IMPACT project has engendered the formation of the QSP-UK network, it is jointly funded by the Engineering and Physical Services Research Council (EPSRC) and the Medical Research Council with additional financial support from AstraZeneca, Pfizer and GlaxoSmithKline.

The aim of the QSP-UK is "to bring and nurture this new emerging area of science to the UK research space."

It held annual network workshops in 2015 and 2016 and has further ones planned for 2017 and 2018 plus satellite meetings and webinars organised by individual members. Several of the members of the IMPACT project are actively involved in the running of the QSP-UK network.

There is a proposal to establish a new Centre for Doctoral Training (CDT) in the area of QSP within the School of Engineering at UoW. The CDT will utilise and dovetail with existing postgraduate training offered by the UoW and builds on the work already successfully completed under the Marie Curie ITN IMPACT project.

In particular the establishment of this CDT Lite will create a step change in pharmacokinetic and pharmacodynamic (PKPD) modelling and pharmaceutical production research internationally by creating a unique team of qualified postgraduates who have been exposed to real life applications/case studies whilst working with an internationally leading pharmaceutical companies and research institutes during their period of academic training towards their PhDs. The research students will solve real life modelling problems during their training, and thus can immediately become involved in, and function in, drug development and pharmaceutical processing projects within industry.

The formation of this CDT Lite widens the collaboration with the leading pharmaceutical companies and other potentially interested parties, namely AZ, Pfizer, GlaxoSmithKline, Novartis, Merck, Bayer, the Liverpool School of Tropical Medicines, the School of Pharmacy (at the University of Manchester) and The Binding Site.

The partner organisations working on the IMPACT project are submitting a follow-up proposal for a further, much larger project along similar lines to the IMPACT project in order to continue the training of Early Stage Researchers and help address the severe shortage that exists within the pharmaceutical industry. If successful this project will be led by UoW with two academic partners, three industrial partners, three associate partners and will provide training for 15 ESRs.